跳至主要内容
临床试验/IRCT20220723055534N1
IRCT20220723055534N1招募中3 期

The effect of colchicine on reperfusion arrhythmias in ST-elevation myocardial infarction (STEMI) patients treated with Primary Percutaneous Coronary Intervention (PPCI)

Qazvin University of Medical Sciences0 个研究点目标入组 154 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
154

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Patients with STEMI that are candidates for PPCI

排除标准

  • Patients who previously used Colchicine or Prednisolone for any reason
  • Contraindications of Colchicine, including sensitivity to Colchicine, kidney failure (GFR < 10), liver failure (AST - ALT above 5 times normal) and definite history of serious liver diseases (such as hepatitis, hemochromatosis, Wilson's disease, cirrhosis)
  • Drugs that interact with risk X with colchicine

研究者

相似试验